Giugliano D, Scappaticcio L, Longo M, Bellastella G, Esposito K (2021) GLP-1 receptor agonists vs
However, due to (i) rareness of the disease (unfamiliar to most neurologists), (ii) non-inclusion of GNE genetic testing for neurological indications, and (iii) non-specific symptoms at disease onset (foot-drop, balance impairment), the diagnosis of these patients is difficult and often delayed
This allows the B12 to absorb directly into your bloodstream, bypassing the digestive system
1 mg/kg twice a day) were started to reduce cerebral edema and intracranial pressure
selective bottom-up checks, such as sampled manufacturer sales and online unit estimates, validate totals
Montague, C